Skip to content
HowShorted

LA JOLLA PHARMACEUTICAL CO short interest in 2021

In 2021, LA JOLLA PHARMACEUTICAL CO's disclosed short interest ran from 11.46% of shares outstanding on 15 Jan 2021 to 2.48% on 31 Dec 2021, a change of -8.98 percentage points. The year's high was 11.46% on 15 Jan 2021 and its low 1.02% on 15 Nov 2021, averaging 6.72% across 23 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 17.88 days on 15 Apr 2021. Full history: LA JOLLA PHARMACEUTICAL CO.

Cite this page
Plain
Wikipedia
BibTeX

By year: 2018 · 2019 · 2020 · 2021 · 2022

Aggregate net short position time series for LA JOLLA PHARMACEUTICAL CO in 2021

2021 in figures

Start of year
11.46% (15 Jan 2021)
End of year
2.48% (31 Dec 2021)
Change
-8.98 pp
High
11.46% (15 Jan 2021)
Low
1.02% (15 Nov 2021)
Average
6.72%
Highest days to cover
17.88 (15 Apr 2021)
SEC filings marked
4

Every report in 2021

LA JOLLA PHARMACEUTICAL CO short interest in 2021
SettlementShort interestDays to coverFilings since previous
15 Jan 202111.46%1.00
29 Jan 20219.73%4.94
12 Feb 20218.74%5.07
26 Feb 20219.36%8.88
15 Mar 202110.89%10.7010-K filed
31 Mar 202110.92%13.55
15 Apr 202111.13%17.88
30 Apr 20219.23%14.95
14 May 20218.51%12.1410-Q filed
28 May 20218.90%8.81
15 Jun 20218.54%7.39
30 Jun 20216.57%3.99
15 Jul 20216.29%10.17
30 Jul 20216.13%16.89
13 Aug 20215.69%8.8110-Q filed
31 Aug 20215.06%13.33
15 Sep 20215.15%16.43
30 Sep 20215.07%14.58
29 Oct 20211.09%4.07
15 Nov 20211.02%3.7610-Q filed
30 Nov 20211.05%1.38
15 Dec 20211.55%2.20
31 Dec 20212.48%6.37

See also: LA JOLLA PHARMACEUTICAL CO's full history · most shorted US stocks of 2021 · today's US league.

About this data

US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.